Aster Insights
10902 N. McKinley Drive
Tampa
Florida
33612
United States
Tel: 813-745-4261
Website: https://www.asterinsights.com/
Email: info@m2gen.com
21 articles about Aster Insights
-
ORIEN to Present Abstracts at 65th Annual ASH Meeting Utilizing Aster Insights' Avatar Platform
12/8/2023
Aster Insights today announced upcoming research presentations at the American Society of Hematology's (ASH) 65th Annual Meeting December 9-12 in San Diego, CA.
-
Twist Bioscience and Aster Insights Partner on Launch of Next Generation Oncology Panel for Cancer Research
4/27/2023
Twist Bioscience Corporation and Aster Insights today announced the availability of the AsterExome panel, which can simultaneously enable whole exome sequencing (WES) with additional coverage for target regions known to contain 620 genes associated with cancer.
-
M2GEN Rebrands to Aster Insights
4/14/2023
M2GEN today announced it is rebranding, changing the company's name to Aster Insights™.
-
ORIEN Researchers to Present Key Findings Utilizing M2GEN's Avatar Data at AACR Annual Meeting
4/7/2023
M2GEN , an oncology-focused health informatics solutions company, today announced its participation as a presenter, exhibitor, and research partner at the American Association for Cancer Research (AACR) Annual Meeting April 14-19, 2023.
-
M2GEN Appoints Kyle Dunn as Chief Revenue Officer to Deliver Next Phase of Company's Growth
10/17/2022
M2GEN, a bioinformatics company accelerating discoveries in oncology research through industry-leading data and analytics, today announced the appointment of Kyle Dunn to its executive team as Chief Revenue Officer.
-
Computer Engineers in the Life Sciences: How Technological Advancements are Increasing Demand
8/29/2022
With technological advancements in the life science field comes a higher demand for professionals with tech backgrounds, specifically computer engineers, to help make it all happen. -
M2GEN Expands World-Class Executive Leadership Team; Appoints Melissa Honour, MPH, as Chief Product Officer
7/12/2022
M2GEN today announced the appointment of Melissa Honour, MPH, to its executive leadership team as Chief Product Officer.
-
Biopharma Executive Perspectives on 2022
1/10/2022
BioSpace sat down with 12 executives who shared their thoughts on the coming year and decade. -
M2GEN Announces Collaboration with Microsoft to Advance Bioinformatics Solutions for Oncology
12/9/2021
M2GEN will utilize Microsoft technologies to power its data and analytics platform.
-
M2GEN-supported research network ORIEN® begins COVID-19 study in cancer patients funded through the ORIEN Foundation
10/1/2020
The Oncology Research Information Exchange Network (ORIEN), an alliance of 18 of the top national cancer centers, announced today the initiation of a COVID-19 study in cancer patients funded through the ORIEN Foundation. ORIEN members have the unique potential to contribute significantly to understanding not only the short-term effects
-
M2GEN and Discovery Life Sciences Enter into Agreement to Leverage M2GEN's New Oncology-Focused Bioinformatics Support Services
9/25/2020
M2GEN announced today that it has entered into an agreement with Discovery Life Sciences, a global leader in biospecimen solutions, genomic, cell, and immunohistochemistry (IHC) services, to provide M2GEN's recently launched oncology-focused bioinformatics support services.
-
M2GEN® Appoints Chris Tunnell Vice President of Global Sales
5/7/2020
M2GEN, an oncology-focused health informatics solutions company with the mission to help patients access the best treatment options by leveraging their clinical and molecular data to accelerate the discovery, development and delivery of tailored and more personalized therapies, announced today the appointment of Chris Tunnell as Vice Pres
-
BioSpace Movers & Shakers, Aug. 16
8/16/2019
Biopharma companies strengthen their executive ranks and boards with new additions. -
M2Gen® Appoints Dr. Helge Bastian President and Chief Executive Officer
8/14/2019
Bastian succeeds M2Gen Executive Chair William S. Dalton, M.D., Ph.D., who has served as interim CEO since September 2018.
-
M2Gen Announces BMS' Participation in ORIEN Avatar Research Program
10/27/2017
M2Gen announced today that Bristol-Myers Squibb has joined the Oncology Research Information Exchange Network Avatar Research Program.
-
Hearst Invests In H. Lee Moffitt Cancer Center & Research Institute Subsidiary M2Gen
9/20/2017
-
AbbVie And M2Gen Announce New Collaboration For The Oncology Research Information Exchange Network (ORIEN) Avatar Research Program
3/28/2017
-
M2Gen Announces That Merck & Co. Joins The Oncology Research Information Exchange Network (ORIEN) Avatar Research Program
1/5/2017
-
M2Gen Selects DNAnexus To Manage Molecular Data For ORIEN Avatar Research Program
9/22/2016
-
Takeda And M2Gen Collaborate With ORIEN To Speed Clinical Development And Discovery Of Cancer Treatments Through Health Informatics
6/16/2016